ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cloning immunology microbiology

Uses Of Enzyme Immunoassays Growing In Laboratories And Clinics
Holly Ahern | Feb 6, 1994 | 9 min read
Life Technologies P.O. Box 6009 8451 Helgerman Court Gaithersburg, Md. 20884 (301) 840-4150 Fax: (800) 331-2286 MGM Instruments Inc. 925 Sherman Ave. Hamden, Conn. 06514 (203) 248-4008 Fax: (203) 288-2621 Nordic Immunological Labs Drawer 2517 Capo Beach, Calif. 92624 (714) 498-4467 Fax: (714) 361-0138 Organon Teknika/ Biotechnology Research Institute 1330 Piccard Dr. Rockville, Md. 20850-4396 (800) 354-0809 Fax: (301) 840-2161
Making Things Grow: Insect Cells, Stem Cells, and Primary Cell Lines All Pose Challenges for Cell Culturists
Laura Defrancesco | Jun 21, 1998 | 5 min read
Date: June 22, 1998 Insect Cell Culture Media, Suppliers of Primary Cell Culture Media Advantages for Protein Expression Studies Since the mid-1950s cultures of insects--cockroaches, fruit flies, and leafhoppers, to name a few--have been the object of quiet study by physiologists and cell biologists. But along came genetic engineering and suddenly insect cultures have been put in the spotlight since they provide advantages over both bacterial and mammalian systems for recombinant protein prod
Mafia Wars
Jef Akst | May 31, 2010 | 10+ min read
An increasing amount of data is showing that the cellular battle between pathogens and hosts needs much more than a simple military metaphor to describe it—think undercover infiltration, front organizations, and forced suicide.
Human Clinical Trials Begin For Cervical Cancer Vaccines
Steve Bunk | Oct 26, 1997 | 6 min read
Efforts are under way to develop a vaccine against one of the world's deadliest illnesses, cervical cancer. Along with a number of university research laboratories, at least a half-dozen biotechnology and pharmaceutical companies are beginning clinical trials or are in preclinical development of such drugs. Efficacy in humans remains to be firmly established, but if the vaccines progress to later-phase trials, challenging jobs for immunologists, microbiologists, and biochemists will multiply. "

Run a Search

ADVERTISEMENT